Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (5), 1235-1240
- https://doi.org/10.1161/01.str.0000068406.30514.31
Abstract
Background and Purpose— We sought to investigate the impact of hyperglycemia before reperfusion on long-term outcome in patients treated with intravenous tissue plasminogen activator (tPA). Methods...Keywords
This publication has 19 references indexed in Scilit:
- Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy studyAnnals of Neurology, 2002
- Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical PracticeCirculation, 2002
- European Stroke Initiative (EUSI) Recommendations for Stroke Management The European Stroke Initiative Writing CommitteeEuropean Journal of Neurology, 2000
- In Vivo Uptake of [3H]Nimodipine in Focal Cerebral Ischemia: Modulation by HyperglycemiaJournal of Cerebral Blood Flow & Metabolism, 1997
- Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up studyBMJ, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.Stroke, 1994
- Normoglycemia (Not Hypoglycemia) Optimizes Outcome from Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 1994
- Thrombolytic Agents in the Treatment of StrokeClinical Neuropharmacology, 1990
- Hyperglycemia Increases Infarct Size in Collaterally Perfused but Not End-Arterial Vascular TerritoriesJournal of Cerebral Blood Flow & Metabolism, 1988